Financials in USD. Standardized financial statements.
A compact view of how Cellev8 Nutrition Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $283,887 | $198,768 | $234,598 | $31,132 | $18,590 | $98,195 | $2,928 | $65,099 | $58,744 | $476,338 |
| Revenue Growth? | +42.8% | -15.3% | +653.6% | +67.5% | -81.1% | +3253.7% | -95.5% | +10.8% | -87.7% | 0.0% |
| Cost of Revenue? | $463,044 | $499,832 | $101,579 | $19,809 | $11,960 | $54,905 | $30,632 | $446,241 | $412,430 | $986,337 |
| Gross Profit? | -$179,157 | -$301,064 | $133,019 | $11,323 | $6,630 | $43,290 | -$27,704 | -$381,142 | -$353,686 | -$510,000 |
| Gross Margin? | -63.1% | -151.5% | +56.7% | +36.4% | +35.7% | +44.1% | -946.2% | -585.5% | -602.1% | -107.1% |
| Operating Expenses? | $1.32M | $917,670 | $764,657 | $377,896 | $460,458 | $327,171 | $288,672 | $411,923 | $1.14M | $841,509 |
| Operating Income? | -$1.50M | -$1.22M | -$631,638 | -$366,570 | -$453,830 | -$283,880 | -$316,380 | -$793,060 | -$1.49M | -$1.35M |
| EBITDA? | -$1.50M | $390,248 | -$626,238 | -$360,773 | -$451,033 | -$286,641 | -$315,074 | -$793,065 | -$1.48M | -$630,448 |
| Income Before Tax | -$1.59M | $264,031 | -$725,136 | -$488,302 | -$572,753 | -$979,411 | -$1.46M | -$1.49M | -$2.10M | -$1.07M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$1.59M | $264,031 | -$725,136 | -$488,302 | -$572,753 | -$979,411 | -$1.46M | -$1.49M | -$2.10M | -$1.07M |
| EPS? | $-0.01 | $0.00 | $-0.01 | $-0.00 | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.03 | $-0.02 |
| Diluted EPS? | $-0.01 | $0.00 | $-0.01 | $-0.00 | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.03 | $-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality